<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23739691</article-id>
      <article-id pub-id-type="pmc">3750893</article-id>
      <article-id pub-id-type="doi">10.1590/S0365-05962013000200015</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>American tegumentary leishmaniasis: an uncommon clinical
and histopathological presentation<xref ref-type="fn" rid="fn01"><sup>*</sup></xref></article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Leishmaniose tegumentar americana: uma apresenta&#xE7;&#xE3;o cl&#xED;nica e
histopatol&#xF3;gica incomum</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Adriano</surname>
            <given-names>Adrilena Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leal</surname>
            <given-names>Paula Azevedo Borges</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Breckenfeld</surname>
            <given-names>Marcelle Parente</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Igor dos Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almeida</surname>
            <given-names>Clarisse</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Sousa</surname>
            <given-names>Ant&#xF4;nio Ren&#xEA; Di&#xF3;genes</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Resident Physician in the Dermatology Department of the Dona Lib&#xE2;nia
Dermatology Center (CDERM) &#x2013; Fortaleza (CE), Brazil</aff>
      <aff id="aff2"><label>2</label> Pathologist &#x2013; Dermatopathology Preceptor in the Dermatology Department
of the Dona Lib&#xE2;nia Dermatology Center (CDERM) &#x2013; Fortaleza (CE), Brazil</aff>
      <aff id="aff3"><label>3</label> Asssitant Dermatologist Physician in the Dermatology Department of the
Dona Lib&#xE2;nia Dermatology Center (CDERM) &#x2013; Fortaleza (CE), Brazil</aff>
      <aff id="aff4"><label>4</label> Dermatologist Physician and Dermatology Residency Coordinator in the
Dermatology Department of the Dona Lib&#xE2;nia Dermatology Center (CDERM) &#x2013; Fortaleza (CE),
Brazil</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Adrilena Lopes Adriano - Rua Pedro I, 1033 - Centro -
60035-101, Fortaleza, CE - Brazil - E-mail: <email>adrilena@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>2</issue>
      <fpage>260</fpage>
      <lpage>262</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>1</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>3</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a case of an unusual presentation of American Tegumentary Leishmaniasis
involving a male patient with a solitary lesion on the ear lobe, persisting with
minimal increase for at least six months without ulceration or related symptoms. The
histological sections showed epithelial atrophy and a large number of structures
consistent with Leishmania sp. amastigotes within macrophages. Treatment commenced
with meglumine antimoniate resulting in regression of the condition. This report is
of importance given the unusual clinical manifestation and histopathological findings
in this case and the fact that there was low correlation with the extended duration
of the disease.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Relatamos um caso de apresenta&#xE7;&#xE3;o incomum de leishmaniose tegumentar americana com
les&#xE3;o solit&#xE1;ria no l&#xF3;bulo da orelha de um paciente do sexo masculino com m&#xED;nimo
aumento em, pelo menos, seis meses, sem ulcera&#xE7;&#xE3;o ou sintomas relacionados. Os cortes
histol&#xF3;gicos mostraram atrofia epitelial e um grande n&#xFA;mero de estruturas compat&#xED;veis
com amastigotas de Leishmania sp. no interior de macr&#xF3;fagos. O tratamento foi
iniciado com antimoniato de meglumina, com regress&#xE3;o do quadro. A import&#xE2;ncia desse
relato de caso &#xE9; devido &#xE0; apresenta&#xE7;&#xE3;o cl&#xED;nica e histopatol&#xF3;gica at&#xED;pica e sua baixa
correla&#xE7;&#xE3;o com a dura&#xE7;&#xE3;o prolongada da doen&#xE7;a.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Leishmania</kwd>
        <kwd>Leishmaniasis, cutaneous</kwd>
        <kwd>Zoonoses</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>American Tegumentary Leishmaniasis (ATL) is an infectious zoonotic disease caused by the
protozoan parasite <italic>Leishmania</italic> spp, transmitted to man and other mammals
through the bites of <italic>Phlebotomus</italic> sandflies. ATL in the New World is
widespread from the south of the United States to the north of Argentina.<sup><xref ref-type="bibr" rid="r01">1</xref></sup></p>
      <p>In Brazil ATL is found in every state and there has been a high incidence of the
disease over the past 20 years, with 26,057 new cases on average per annum.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> 6% of the cases of ATL in the country are found in the state of Cear&#xE1; (northeast
Brazil), mainly on the plateaus.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> We report a case of an uncommon manifestation of ATL.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>In September 2010, a 42-year-old male patient from a rural area in Cear&#xE1; noticed the
onset of a nodule on his ear. Over the ensuing months, there was a minimal swelling of
the lesion. Treatment with topical steroids and antibiotics produced no improvement.</p>
      <p>Physical examination revealed an erythematous nodule of fibrous-elastic tissue on the
right ear lobe with no purulent discharge. The patient, with no history of local trauma,
did not experience localized pain, itching or constitutional symptoms (<xref ref-type="fig" rid="f01">Figure 1</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Aspect of the lesion pretreatment: a nodule of fibrous-elastic tissue on the right
ear lobe</p>
        </caption>
        <graphic xlink:href="abd-88-0260-g01"/>
      </fig>
      <p>The patient&#xB4;s blood glucose was normal and the VDRL test was nonreactive. Serologic
tests for HIV were not undertaken. A biopsy was carried out about six months after the
onset of the clinical condition.</p>
      <p>The histological sections showed epithelial atrophy, and Grenz's zone in the dermis,
with a dense superficial and deep lymphoplasmacytic and histiocytic infiltrate. A large
number of structures consistent with <italic>Leishmania </italic>sp. amastigotes was
observed in macrophages. The results of the Leishmanin skin test (LST) were positive,
with 10 mm of induration (<xref ref-type="fig" rid="f02">Figure 2</xref> and <xref ref-type="fig" rid="f03">3</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Epidermal atrophy and infiltrate in the dermis composed of lymphocytes,
plasmocytes and histiocytes. There are no granulomatous formations in the sample
(H&amp;E 400x)</p>
        </caption>
        <graphic xlink:href="abd-88-0260-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>There is a large number of leishmania amastigotes within macrophages.</p>
        </caption>
        <graphic xlink:href="abd-88-0260-g03"/>
      </fig>
      <p>The patient missed follow-up but returned three months later with no changes on the
lesion. Since no abnormalities were found in the general laboratory tests, treatment was
started with meglumine antimoniate (15mg/kg) over 20 days. Two months after the end of
therapy the lesions showed clear signs of regression (<xref ref-type="fig" rid="f04">Figure 4</xref>).</p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Regression of the lesion four months after the end of the therapy</p>
        </caption>
        <graphic xlink:href="abd-88-0260-g04"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>ATL is characterized by a spectrum of cutaneous manifestations. The classic initial
clinical sign of the disease is the appearance of an erythematous nodule, which may be
single or multiple, usually located in an exposed region of the tegument where, after a
few months, it develops into ulcers with indurated raised outer borders, regular
contours and a cross-grained background with or without a seropurulent exudate. The most
common presentation of ATL is an ulcer (63%-91% of cases). However, some lesions do not
ulcerate as in diffuse cutaneous leishmaniasis. The patient under study had a nodular
lesion for at least nine months with no signs of ulceration.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref>V</sup>
</p>
      <p>When attempting diagnosis of ATL it is important to investigate the history, the
clinical findings, the epidemiological information, and to carry out additional tests.
When a typical clinical scenario appears in endemic regions, the diagnosis does not
usually present any difficulty. However, atypical cases can result in a misdiagnosis,
even in endemic regions. Some authors argue that ATL is a "great imitator" of other conditions. Tests should be
carried out for a differential diagnosis.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>The ear has not been reported as a common site of ATL involvement. In an observational
study by Murback (2011) over 10 years, the ear was the site of inoculation in only one
out of 47 patients.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> In another study in Iraq involving 107 patients with ATL, only one patient had
an infection on the ear.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> According to Martinelli (2005), the ear is an extremely rare site for ATL.<sup><xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>Our patient showed no impairment of cell-mediated immunity, which could be verified by
the positivity of the LST, which was consistent with the duration of the skin lesion.
This skin test indicates delayed hypersensitivity reaction to Leishmania, which plays an
important role in disease resolution and healing. The test characteristically becomes
positive 4-6 weeks after initiation of the skin lesion. <sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>Furthermore, the diagnosis is supported by isolating <italic>Leishmania </italic>sp. in
culture or by detecting amastigotes in histological sections, although parasitological
demonstration is not always attained. In a study in Rio de Janeiro (2008) a
histopathological analysis of 20 cases showed that amastigotes were found in only two
samples.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> Venkataraman&#xB4;s previous study (2001) evaluated the clinical and
histopathological correlation of ATL in 40 patients, where four histological patterns
were identified: 1) diffuse macrophage infiltration without necrosis, involving over 100
amastigotes in a standard section; 2) macrophage infiltration with necrosis, with 10-100
amastigotes in a standard section; 3) early reactive granuloma; and 4) established
epitheloid granuloma, without amastigotes. The number of amastigotes decreases as the
disease evolves. In lesions of 3-12 months duration pattern 2 above was the most common.
Venkataraman <italic>et al </italic>also found that the most common epithelial change
was pseudo-epithelial hyperplasia. Only 10% of the patients had atrophy of the
epidermis, but all of them experienced the chronic phase (over 12 months).<sup><xref ref-type="bibr" rid="r08">8</xref></sup> In addition, when the histopathological examination shows macrophages filled
with amastigotes, we must consider the species concerned. In Cear&#xE1;, cases of <italic>L.
braziliensis </italic>and <italic>L. amazonensis </italic>have been detected. In the
infection by <italic>L. braziliensis</italic>, the infected cells are usually evidenced
in the first weeks of the disease. After this period the parasites become rarer, with a
dense infiltrate of non-infected plasma cells, lymphocytes and macrophages. When dealing
with infection by <italic>L. amazonensis</italic>, parasites persist in macrophages for
several months (6 or more). While the case under study was apparently an infection by
<italic>L. amazonensis</italic>, a molecular biology investigation for confirmation
of the species was not however possible. <sup><xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>The treatment of ATL depends on its clinical manifestations as well as on the location
and diameter of the lesion. Treatment includes systemic or intralesional pentavalent
antimonials, sodium stibogluconate and meglumine antimonials (Glucantime(r)) and
cryotherapy. We chose the systemic meglumine antimoniate (15 mg/kg/day) for 20 days,
with good control. <sup><xref ref-type="bibr" rid="r10">10</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Study conducted at the Dermatology Department of the Dona Lib&#xE2;nia Dermatology
Center (CDERM) - Fortaleza (CE), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#xE9;rio da Sa&#xFA;de. Secretaria de Vigil&#xE2;ncia em Sa&#xFA;de</collab>
          </person-group>
          <source xml:lang="pt">Manual de Vigil&#xE2;ncia da Leishmaniose Tegumentar
Americana</source>
          <edition>2 ed.</edition>
          <publisher-loc>Bras&#xED;lia</publisher-loc>
          <publisher-name>Minist&#xE9;rio da Sa&#xFA;de</publisher-name>
          <year>2007</year>
          <fpage>13</fpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#xE9;rio da Sa&#xFA;de. Sistema Nacional de Vigil&#xE2;ncia em Sa&#xFA;de</collab>
          </person-group>
          <source xml:lang="pt">Sistema nacional de vigil&#xE2;ncia em sa&#xFA;de: relat&#xF3;rio de situa&#xE7;&#xE3;o:
Ceara</source>
          <edition>2. ed.</edition>
          <publisher-loc>Bras&#xED;lia</publisher-loc>
          <publisher-name>Minist&#xE9;rio da Sa&#xFA;de</publisher-name>
          <year>2006</year>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vieira-Gon&#xE7;alves</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pirmez</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jorge</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Rutowitsch</surname>
              <given-names>MS</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Clinical features of cutaneous and disseminated cutaneous
leishmaniasis caused by Leishmania Viannia) braziliensis in Paraty, Rio de
Janeiro</article-title>
          <source>Int J Dermatol</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>926</fpage>
          <lpage>932</lpage>
          <pub-id pub-id-type="pmid">18937655</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murback</surname>
              <given-names>NDN</given-names>
            </name>
            <name>
              <surname>Hans</surname>
              <given-names>G</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>RAS</given-names>
            </name>
            <name>
              <surname>NakazatoI</surname>
              <given-names>KRO</given-names>
            </name>
            <name>
              <surname>Dorval</surname>
              <given-names>MEMC</given-names>
            </name>
          </person-group>
          <article-title>American cutaneous leishmaniasis: clinical, epidemiological and
laboratory studies conducted at a university teaching hospital in Campo Grande,
Mato Grosso do Sul, Brazil</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>55</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">21437523</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>AlSamarai</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>AlObaidi</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis in Iraq</article-title>
          <source>J Infect Dev Ctries</source>
          <year>2009</year>
          <volume>3</volume>
          <fpage>123</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">19755742</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sabri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khatib</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kanj-Sharara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Husseini</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Nuwayri-Salti</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Semaan</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Leishmaniasis of the auricle mimicking carcinoma</article-title>
          <source>Am J Otolaryngol</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>285</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">19563944</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Giorgini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Minu</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Minu</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Orsi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leoncini</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis: An atypical case</article-title>
          <source>Int J Dermatol</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>38</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">15663657</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venkataram</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moosa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Devi</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Histopathological spectrum in cutaneous leishmaniasis: a study in
Oman</article-title>
          <source>Indian J Dermatol Venereol Leprol</source>
          <year>2001</year>
          <volume>67</volume>
          <fpage>294</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">17664781</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moraes</surname>
              <given-names>MAP</given-names>
            </name>
            <name>
              <surname>Silveira</surname>
              <given-names>FT</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Histopatologia da forma localizada de leishmaniose cutanea por
Leishmania (Leishmania) amazonensis</article-title>
          <source>Rev Inst Med Trop S&#xE3;o Paulo</source>
          <year>1994</year>
          <volume>36</volume>
          <fpage>459</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="pmid">7569614</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>OLS</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Advances in the treatment of cutaneous leishmaniasis in the new world
in the last ten years: a systematic literature review</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>497</fpage>
          <lpage>506</lpage>
          <pub-id pub-id-type="pmid">21738967</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
